Celldex
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Celldex and other ETFs, options, and stocks.About CLDX
Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases.
CLDX Key Statistics
Stock Snapshot
With a market cap of 2.51B, Celldex(CLDX) trades at $32.04. The stock has a price-to-earnings ratio of -7.57.
During the trading session on 2026-05-12, Celldex(CLDX) shares reached a daily high of $32.45 and a low of $31.87. At a current price of $32.04, the stock is +0.5% higher than the low and still -1.3% under the high.
Trading volume for Celldex(CLDX) stock has reached 59.27K, versus its average volume of 681.52K.
The stock's 52-week range extends from a low of $18.47 to a high of $35.79.
The stock's 52-week range extends from a low of $18.47 to a high of $35.79.
CLDX News
Celldex Therapeutics recently reported first-quarter 2026 results, with revenue falling to US$15,000 from US$695,000 a year earlier and net loss widening to US$...
Advertisement Celldex Therapeutics (CLDX) stock snapshot Celldex Therapeutics (CLDX) has drawn fresh attention after recent trading moves, with the stock show...
Reports Q1 revenue $15K, consensus $861K. Cash, cash equivalents and marketable securities as of March 31, were $451.5M compared to $518.6M as of December 31, 2...
Analyst ratings
93%
of 15 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.